# Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)

> **NCT00177684** · PHASE3 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 48 (—)

## Conditions studied

- Lung Transplantation
- Fungal Infections

## Interventions

- **DRUG:** Amphotericin B

## Key facts

- **NCT ID:** NCT00177684
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 48 (—)
- **Last updated:** 2008-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177684, "Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00177684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*